Related Experiment Video
Updated: Aug 15, 2026

2D and 3D Matrices to Study Linear Invadosome Formation and Activity
Published on: June 2, 2017
Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
K Takahashi1, H Eto, K K Tanabe
1Department of Surgery, Massachusetts General Hospital, Boston 02114, USA.
Abstract:
CD44 is a family of cell-surface-adhesion proteins that are thought to play an important role in cancer invasion and metastasis. However, the specific mechanisms by which CD44 expression modulates invasion or metastasis are not well understood. In the current study, we have demonstrated that treatment of human melanoma cells with a CD44 MAb, F10-44-2, induces up-regulation of matrix metalloproteinase-2 (MMP-2) protein and mRNA. Moreover, treatment of melanoma cells with MAb F10-44-2 enhances their migration through gelatin-coated membranes and invasion through reconstituted basement membranes. Treatment of melanoma cells with several known CD44 ligands, including hyaluronate, extracellular-matrix proteins, and osteopontin, did not induce MMP-2 production. CD44 binding by F10-44-2 MAb results in induction of MMP-2 expression, which is associated with enhanced cell migration and invasion. These findings have several implications for investigations into tumor metastasis, development, and lymphocyte function.
Insights
Targeting CD44 with the F10-44-2 antibody up-regulates matrix metalloproteinase-2 (MMP-2), enhancing melanoma cell migration and invasion. This suggests a novel mechanism for controlling cancer metastasis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- CD44, a cell-surface adhesion protein, is implicated in cancer invasion and metastasis.
- The precise mechanisms by which CD44 influences these processes remain unclear.
Purpose of the Study:
- To investigate how CD44 expression affects melanoma cell invasion and metastasis.
- To elucidate the role of CD44-mediated signaling in matrix metalloproteinase-2 (MMP-2) regulation.
Main Methods:
- Human melanoma cells were treated with a CD44 monoclonal antibody (MAb), F10-44-2.
- MMP-2 protein and mRNA levels were quantified.
- Cell migration and invasion assays were performed using gelatin-coated and reconstituted basement membranes.
Main Results:
- Treatment with F10-44-2 MAb induced significant up-regulation of MMP-2 protein and mRNA in melanoma cells.
- Melanoma cell migration and invasion were enhanced following treatment with F10-44-2 MAb.
- Known CD44 ligands did not induce MMP-2 production, indicating a specific antibody-mediated effect.
Conclusions:
- CD44 binding by the F10-44-2 MAb triggers MMP-2 expression.
- This MMP-2 induction is directly associated with enhanced melanoma cell migration and invasion.
- Findings provide insights into tumor metastasis, development, and lymphocyte function.
More Related Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Role of Matrix Metalloproteases in Degradation of ECM
A...
Overview of Cell-Matrix Interactions